Friday, February 8, 2013

South Dakota Board of Pharmacy's Position Regarding Office Use

The board receives frequent advice from pharmacists related to prescription the pharmacy may receive from a prescriber indicating the “for office use” on the prescription. SDCL 36-11-2 (22) defines this. “Prescription drug order,” a written or oral order of a practitioner for a drug or drug device for a specific patient. Therefore, a prescription that is not patient specific is not valid. If a practitioner requests medication from a pharmacy, this transaction is considered a wholesale distribution. For non-controlled substances, the invoice must contain the name, strength, and dosage form of the medication, date of the transaction, name and address of the seller and the purchaser. For controlled substances, the record must contain all the information stated above, as well as the DEA numbers of the both the seller and the purchaser. If the medication is a CII controlled substance, the purchaser must execute a DEA Form 222 to the seller prior to the transaction. Records for controlled substance transaction must be maintained in a readily retrievable manner for a minimum of 2 years.  

1 comment:

Kenneth Woliner, MD said...

So, does this mean a pharmacy has to get a wholesale distributor's permit to send medications into South Dakota for "office use"?

And what is to stop a pharmacy from saying, "We need a name, any name, so we can say in our records that this "office use" medication was for a specific patient (wink, wink)"? (And then the physician office using the name of their office manager, or sister, etc, and then using that medication for anyone that walks through the door)

Kenneth Woliner, MD